from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1815/-

LFCtreatmentdescriptionclass of inhibitor

1.927

Amikacinug/mL Amikacintranslation

2.502

Cap5-10ug/mL Capreomycintranslation

2.423

Rox10-50 ug/mL Roxithromycintranslation

0.142

SM2-5 ug/mL Streptomycintranslation

2.004

Tet5-10 ug/mL Tetracyclinetranslation

0.061

Rif0.2-5ug/mL Rifampicintranscription

1.973

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.097

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.600

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.682

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.213

Clofazimine10-13 ug/mL Clofaziminerespiration

0.702

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.774

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.026

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.423

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.568

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.259

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.043

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.233

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.216

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.712

KCN5-20 ug/mL Potassium cyaniderespiration

-1.504

NaN30.2-2 mM Sodium aziderespiration

1.864

Nigericin50 uM Nigericinrespiration

-0.586

TRC10-150 ug/mL Triclosanrespiration

-0.863

TRZ10-25 ug/mL Thioridazinerespiration

0.380

Valinomycin0.5-10 uM Valinomycinrespiration

-0.287

ZnSO42 mM ZnSO4respiration

-1.045

menadione6-10 ug/mL Menadionerespiration

-0.945

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.654

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.293

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.659

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.816

NRP_1Non-replicating persistence stage 1dosRassociated

0.223

Amp0.2mg/mL AmpicillincellWall

-0.559

Cephalexin20-100 ug/mL CephalexincellWall

0.025

Cerulenin0.32-5 ug/mL CerulenincellWall

0.769

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.378

EMB10-20 ug/mL EthambutolcellWall

-0.389

Eta12-40 ug/mL EthionamidecellWall

-0.242

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.809

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.243

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.345

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.045

BZA0.12 mg/mL BenzamidearomaticAmides

0.427

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.409

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.292

H2O24 mM hydrogen peroxideDNAdamaging

0.829

Levo10 ug/mL LevofloxacinDNAdamaging

-0.105

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.015

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.980

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.179

UVUV-irradiationDNAdamaging

-0.638

ARP41-4 ug/mL Antitubercular compound ARP4?

0.587

Antimycin12.5-50 ug/mL Antimycin A?

0.687

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.170

PA_110-50 ug/mL Antitubercular compound PA-1?

0.155

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.115

PA8240.2-2 ug/mL PA-824?

-0.811

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.279

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.615

Verapamil50 uM Verapamil?

1.075

mercaptoethanol2 mM 2-Mercaptoethanol?

0.630

methoxatin10-20 ug/mL Methoxatin?